Efficacy and safety of cycloserine-containing regimens in the treatment of multidrug-resistant tuberculosis: a nationwide retrospective cohort study in China

BACKGROUND: Our aim was to assess whether the use of cycloserine (CS) would bring additional benefit for multidrug-resistant tuberculosis (MDR-TB) patients, and to estimate the incidence and associated risk factors of adverse drug reactions (ADRs) from CS. PATIENTS AND METHODS: In this study, we ret...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Infect Drug Resist
Päätekijät: Wang, Jing, Pang, Yu, Jing, Wei, Chen, Wei, Guo, Ru, Han, Xiqin, Wu, Limin, Yang, Guangxu, Yang, Kunyun, Chen, Cong, Jiang, Lin, Cai, Chunkui, Dou, Zhi, Diao, Lijuan, Pan, Hongqiu, Wang, Jianyun, Du, Feifei, Xu, Tao, Wang, Lixia, Li, Renzhong, Chu, Naihui
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove Medical Press 2019
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6452793/
https://ncbi.nlm.nih.gov/pubmed/31040707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S194484
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia